ENANTA PHARMACEUTICALS INC Quarterly Common Stock, Shares, Outstanding from Q3 2012 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Enanta Pharmaceuticals Inc quarterly Common Stock, Shares, Outstanding history and growth rate from Q3 2012 to Q2 2024.
  • Enanta Pharmaceuticals Inc Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 21.2M shares, a 0.6% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 21.2M +126K +0.6% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 21.2M +130K +0.62% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 21.2M +272K +1.3% Dec 31, 2023 10-Q 2024-02-08
Q3 2023 21.1M +268K +1.29% Sep 30, 2023 10-Q 2024-08-07
Q2 2023 21.1M +336K +1.62% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 21M +431K +2.09% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 20.9M +378K +1.84% Dec 31, 2022 10-Q 2023-02-08
Q3 2022 20.8M +553K +2.73% Sep 30, 2022 10-K 2023-11-22
Q2 2022 20.7M +509K +2.52% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 20.6M +433K +2.15% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 20.5M +364K +1.81% Dec 31, 2021 10-Q 2022-02-10
Q3 2021 20.2M +161K +0.8% Sep 30, 2021 10-K 2022-11-23
Q2 2021 20.2M +141K +0.7% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 20.2M +199K +1% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 20.1M +332K +1.68% Dec 31, 2020 10-Q 2021-02-09
Q3 2020 20.1M +374K +1.9% Sep 30, 2020 10-K 2021-11-24
Q2 2020 20.1M +388K +1.97% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 20M +317K +1.61% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 19.8M +375K +1.93% Dec 31, 2019 10-Q 2020-02-10
Q3 2019 19.7M +308K +1.59% Sep 30, 2019 10-K 2020-11-25
Q2 2019 19.7M +322K +1.66% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 19.7M +409K +2.12% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 19.4M +285K +1.49% Dec 31, 2018 10-Q 2019-02-08
Q3 2018 19.4M +275K +1.44% Sep 30, 2018 10-K 2019-11-27
Q2 2018 19.4M +270K +1.41% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 19.3M +206K +1.08% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 19.2M +110K +0.58% Dec 31, 2017 10-Q 2018-02-09
Q3 2017 19.1M +84K +0.44% Sep 30, 2017 10-K 2018-11-29
Q2 2017 19.1M +54.2K +0.29% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 19.1M +97.4K +0.51% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 19M +245K +1.3% Dec 31, 2016 10-Q 2017-02-09
Q3 2016 19M +319K +1.71% Sep 30, 2016 10-K 2017-12-11
Q2 2016 19M +328K +1.75% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 19M +266K +1.42% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 18.8M +182K +0.98% Dec 31, 2015 10-Q 2016-02-09
Q3 2015 18.7M +122K +0.66% Sep 30, 2015 10-K 2016-12-09
Q2 2015 18.7M +127K +0.69% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 18.7M +213K +1.15% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 18.6M +647K +3.6% Dec 31, 2014 10-Q 2015-02-06
Q3 2014 18.6M +665K +3.71% Sep 30, 2014 10-K 2015-12-11
Q2 2014 18.6M +755K +4.23% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 18.5M +659K +3.7% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 18M Dec 31, 2013 10-Q 2014-02-13
Q3 2013 17.9M +16.8M +1481% Sep 30, 2013 10-K 2014-12-11
Q2 2013 17.8M Jun 30, 2013 10-Q 2013-08-12
Q1 2013 17.8M Mar 31, 2013 10-Q 2013-05-15
Q3 2012 1.13M Sep 30, 2012 10-K 2013-12-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.